Sept 28 (Reuters) - KNIGHT THERAPEUTICS Inc GUD.TO :
* Says entered into an exclusive distribution agreement with profounda inc to
commercialize impavido
* Under terms, profounda will be responsible for leading all commercial
activities related to impavido in U.S.
* In exchange, profounda will get a share of impavido's u.s. net sales
* Knight is responsible for product supply and regulatory management
* Source text for Eikon ID:nMKW0rbSla
* Further company coverage GUD.TO